This classification framework relies on indicators of both insulin secretion and insulin sensitivity, recognizing that hyperglycemia may result either from a primary deficiency in insulin production, as seen in type 1 diabetes (T1D), or from varying degrees of insulin resistance combined with inadequate compensatory insulin secretion, characteristic of type 2 diabetes (T2D). This evidence concerns the gene INS and type 2 diabetes mellitus.